These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28361606)

  • 1. Targeting active cancer cells with smart bullets.
    Martel S
    Ther Deliv; 2017 Mar; 8(5):301-312. PubMed ID: 28361606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
    Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
    Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paul Ehrlich's magic bullet concept: 100 years of progress.
    Strebhardt K; Ullrich A
    Nat Rev Cancer; 2008 Jun; 8(6):473-80. PubMed ID: 18469827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
    Tavano L; Muzzalupo R
    Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Drug Delivery - From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives.
    Tewabe A; Abate A; Tamrie M; Seyfu A; Abdela Siraj E
    J Multidiscip Healthc; 2021; 14():1711-1724. PubMed ID: 34267523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Smart' nanoparticles as drug delivery systems for applications in tumor therapy.
    Fang Z; Wan LY; Chu LY; Zhang YQ; Wu JF
    Expert Opin Drug Deliv; 2015; 12(12):1943-53. PubMed ID: 26193970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vectors for the delivery of radiopharmaceuticals in cancer therapeutics.
    Chaturvedi S; Mishra AK
    Ther Deliv; 2014 Aug; 5(8):893-912. PubMed ID: 25337647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of molecular targets in cancer drug development: major hurdles and future strategies.
    Hebar A; Valent P; Selzer E
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):23-34. PubMed ID: 23272790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy.
    Joubert N; Denevault-Sabourin C; Bryden F; Viaud-Massuard MC
    Eur J Med Chem; 2017 Dec; 142():393-415. PubMed ID: 28911823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of navigation control strategy for magnetotactic bacteria in microchannel: toward targeting solid tumors.
    Felfoul O; Martel S
    Biomed Microdevices; 2013 Dec; 15(6):1015-24. PubMed ID: 23857666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.
    D'Souza GG; Weissig V
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1135-48. PubMed ID: 19708822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions.
    Shohdy KS; Alfaar AS
    Ther Deliv; 2013 Sep; 4(9):1197-209. PubMed ID: 24024516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination cancer immunotherapy "Expanding Paul Ehrlich's Magic Bullet Concept".
    Elliott RL
    Surg Oncol; 2012 Mar; 21(1):53-5. PubMed ID: 20338747
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic therapeutic delivery using navigable agents.
    Martel S
    Ther Deliv; 2014 Feb; 5(2):189-204. PubMed ID: 24483196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting strategies for bone diseases: signaling pathways and clinical studies.
    Xu H; Wang W; Liu X; Huang W; Zhu C; Xu Y; Yang H; Bai J; Geng D
    Signal Transduct Target Ther; 2023 May; 8(1):202. PubMed ID: 37198232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-penetrating peptides: a shift from magic bullets to magic guns.
    Feron O
    Sci Transl Med; 2010 Jun; 2(34):34ps26. PubMed ID: 20519716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'smart bomb' replaces the 'magic bullet'. Targeted chemotherapy using tumour markers.
    Geelhoed GW
    S Afr J Surg; 1988 Mar; 26(1):1-3. PubMed ID: 3283957
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting the latest hallmark of cancer: another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype.
    Cuperlovic-Culf M; Culf AS; Touaibia M; Lefort N
    Future Oncol; 2012 Oct; 8(10):1315-30. PubMed ID: 23130930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing antibody and small-molecule therapies for cancer.
    Imai K; Takaoka A
    Nat Rev Cancer; 2006 Sep; 6(9):714-27. PubMed ID: 16929325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modular nanotheranostic agents for protistan parasitic diseases: Magic bullets with tracers.
    Maciver SK; Abdelnasir S; Anwar A; Siddiqui R; Khan NA
    Mol Biochem Parasitol; 2023 Feb; 253():111541. PubMed ID: 36603708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.